Found: 68
Select item for more details and to access through your institution.
Safety and risk of febrile recurrence after early antibiotic discontinuation in high-risk neutropenic patients with haematological malignancies: a multicentre observational study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2018, v. 144, n. 4, p. 629, doi. 10.1007/s00432-017-2529-9
- By:
- Publication type:
- Article
Whole-exon sequencing of human myeloma cell lines shows mutations related to myeloma patients at relapse with major hits in the DNA regulation and repair pathways.
- Published in:
- Journal of Hematology & Oncology, 2018, v. 11, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0679-0
- By:
- Publication type:
- Article
Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 1, p. 40, doi. 10.3390/ijms19010040
- By:
- Publication type:
- Article
Durvalumab as monotherapy and in combination therapy in patients with lymphoma or chronic lymphocytic leukemia: The FUSION NHL 001 trial.
- Published in:
- Cancer Reports, 2023, v. 6, n. 1, p. 1, doi. 10.1002/cnr2.1662
- By:
- Publication type:
- Article
Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.755623
- By:
- Publication type:
- Article
Radioimmunothérapie: Les raisons d'une utilisation clinique confidentielle et celles d'un espoir de développement.
- Published in:
- Médecine Sciences, 2019, v. 35, n. 12, p. 1062, doi. 10.1051/medsci/2019206
- By:
- Publication type:
- Article
Efficacy of a short sandwich protocol, methotrexate, gemcitabine, L‐asparaginase and dexamethasone chemotherapy combined with radiotherapy, in localised newly diagnosed NK/T‐cell lymphoma: A French retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. 673, doi. 10.1111/bjh.18689
- By:
- Publication type:
- Article
Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 5, p. e38, doi. 10.1111/bjh.17911
- By:
- Publication type:
- Article
Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 360, doi. 10.1111/bjh.17818
- By:
- Publication type:
- Article
No survival improvement in patients with high‐risk multiple myeloma harbouring del(17p) and/or t(4;14) over the two past decades.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 3, p. 635, doi. 10.1111/bjh.17488
- By:
- Publication type:
- Article
BeEAM (bendamustine, etoposide, cytarabine, melphalan) prior to autologous stem cell transplant for chemosensitive relapses in patients with follicular lymphoma: a prospective multicentre phase II study in Lymphoma Study Association centres<sup>†</sup>
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. e94, doi. 10.1111/bjh.17279
- By:
- Publication type:
- Article
Azacitidine in patients older than 80 years with acute myeloid leukaemia or myelodysplastic syndromes: a report on 115 patients.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 3, p. 461, doi. 10.1111/bjh.16680
- By:
- Publication type:
- Article
BH3 profiling as a tool to identify acquired resistance to venetoclax in multiple myeloma.
- Published in:
- British Journal of Haematology, 2017, v. 179, n. 4, p. 684, doi. 10.1111/bjh.14251
- By:
- Publication type:
- Article
A phase II, single-arm, multicentre study of coltuximab ravtansine ( SAR3419) and rituximab in patients with relapsed or refractory diffuse large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2016, v. 173, n. 5, p. 722, doi. 10.1111/bjh.13992
- By:
- Publication type:
- Article
Correction to: Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Quality of life of survivors 1 year after the diagnosis of diffuse large B-cell lymphoma: a LYSA study.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 2, p. 317, doi. 10.1007/s00277-021-04689-4
- By:
- Publication type:
- Article
Safety and efficacy of temsirolimus in combination with three different immuno-chemotherapy regimens in relapse and refractory mantle cell lymphoma, final results of the T<sup>3</sup> phase IB trial of the LYSA.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Absence of influence of peripheral blood CD34+ and CD3+ graft cell counts on outcomes after reduced-intensity conditioning transplantation using post-transplant cyclophosphamide.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
SMABcare study: subcutaneous monoclonal antibody in cancer care: cost-consequence analysis of subcutaneous rituximab in patients with follicular lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Successful treatment of acute promyelocytic leukemia with arsenic trioxide and all-trans retinoic acid in a double lung and kidney transplanted patient.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2844-6
- By:
- Publication type:
- Article
Melphalan-induced apoptosis in multiple myeloma cells is associated with a cleavage of Mcl-1 and Bim and a decrease in the Mcl-1/Bim complex.
- Published in:
- Oncogene, 2005, v. 24, n. 54, p. 8076, doi. 10.1038/sj.onc.1208949
- By:
- Publication type:
- Article
Novel inosine monophosphate dehydrogenase inhibitor VX-944 induces apoptosis in multiple myeloma cells primarily via caspase-independent AIF/Endo G pathway.
- Published in:
- Oncogene, 2005, v. 24, n. 38, p. 5888, doi. 10.1038/sj.onc.1208739
- By:
- Publication type:
- Article
Ibrutinib Associated with Rituximab-Platinum Salt-Based Immunochemotherapy in B-Cell Lymphomas: Results of a Phase 1b-II Study of the LYSA Group.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1761, doi. 10.3390/cancers14071761
- By:
- Publication type:
- Article
Impact of allogeneic stem cell transplantation comorbidity indexes after haplotransplant using post‐transplant cyclophosphamide.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 20, p. 7194, doi. 10.1002/cam4.4262
- By:
- Publication type:
- Article
A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 2, p. 642, doi. 10.1002/cam4.3648
- By:
- Publication type:
- Article
Thoracic Subcutaneous Infiltration: An Unusual Presentation of Subcutaneous Panniculitis-like T-cell Lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Case Study
90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 2, p. 212, doi. 10.1016/j.clml.2011.03.007
- By:
- Publication type:
- Article
Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
- Published in:
- European Journal of Haematology, 2017, v. 99, n. 1, p. 60, doi. 10.1111/ejh.12891
- By:
- Publication type:
- Article
Prognostic impact of <sup>18</sup>F-fluoro-deoxyglucose positron emission tomography in untreated mantle cell lymphoma: a retrospective study from the GOELAMS group.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 9, p. 1633, doi. 10.1007/s00259-010-1469-2
- By:
- Publication type:
- Article
Long-Term Follow-Up of Acalabrutinib Monotherapy in Patients with Relapsed/Refractory Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. S316, doi. 10.1016/j.clml.2019.07.291
- By:
- Publication type:
- Article
Interim Report from a Phase 2 Multicenter Study of Tazemetostat, an EZH2 Inhibitor: Clinical Activity and Favorable Safety in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S380, doi. 10.1016/j.clml.2017.07.227
- By:
- Publication type:
- Article
Mantle cell lymphoma epidemiology: a population-based study in France.
- Published in:
- 2008
- By:
- Publication type:
- Journal Article
Prognostic Value of <sup>18</sup>F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 156, doi. 10.2967/jnumed.123.265872
- By:
- Publication type:
- Article
Validation of the ΔSUV<sub>max</sub> for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1706, doi. 10.2967/jnumed.123.265871
- By:
- Publication type:
- Article
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor in previously treated mantle cell lymphoma: updated results from the phase 1/2 BRUIN study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
- By:
- Publication type:
- Article
Primary results from the double-blind, placebo-controlled, phase 3 SHINE study of ibrutinib in combination with bendamustine-rituximab (BR) and R maintenance as a first-line treatment for older patients with mantle cell lymphoma (MCL).
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 42
- By:
- Publication type:
- Article
Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-72415-7
- By:
- Publication type:
- Article
A phase 1/2, open‐label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 108, doi. 10.1002/hon.3089
- By:
- Publication type:
- Article
Prognostic value of FDG‐PET/CT response for patient selection before chimeric antigen receptor‐T‐cells therapy in non‐Hodgkin lymphoma.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 4, p. 796, doi. 10.1002/hon.2965
- By:
- Publication type:
- Article
Whole genome copy number analysis in search of new prognostic biomarkers in first line treatment of mantle cell lymphoma. A study by the LYSA group.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 4, p. 446, doi. 10.1002/hon.2750
- By:
- Publication type:
- Article
Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era.
- Published in:
- 2020
- By:
- Publication type:
- journal article
CD200 expression in flow cytometry helps to distinguish mantle cell lymphoma from other CD5-positive B-cell neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Efficacy and long-term toxicity of the rituximab-fludarabine-cyclophosphamide combination therapy in Waldenstrom's macroglobulinemia.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 8, p. 782, doi. 10.1002/ajh.24405
- By:
- Publication type:
- Article
Impact of the practice of touch-massage® by a nurse on the anxiety of patients with hematological disorders hospitalized in a sterile environment, a randomized, controlled study.
- Published in:
- BMC Complementary Medicine & Therapies, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12906-023-04302-3
- By:
- Publication type:
- Article